Business Description
Beam Therapeutics Inc
NAICS : 325411
SIC : 2833
ISIN : US07373V1052
Description
Financial Strength
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 6.51 | |||||
Equity-to-Asset | 0.67 | |||||
Debt-to-Equity | 0.18 | |||||
Debt-to-EBITDA | -1.05 | |||||
Interest Coverage | N/A | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 1.94 | |||||
Beneish M-Score | 0.86 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 1598 | |||||
3-Year EBITDA Growth Rate | 9.5 | |||||
3-Year EPS without NRI Growth Rate | 15.7 | |||||
3-Year FCF Growth Rate | 0.4 | |||||
3-Year Book Growth Rate | 41 |
Momentum Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 46.03 | |||||
9-Day RSI | 37.31 | |||||
14-Day RSI | 34.49 | |||||
6-1 Month Momentum % | 12.85 | |||||
12-1 Month Momentum % | -16.17 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 5.99 | |||||
Quick Ratio | 5.99 | |||||
Cash Ratio | 5.85 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -12.6 | |||||
Shareholder Yield % | -9.49 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Operating Margin % | -50.34 | |||||
Net Margin % | -37.33 | |||||
FCF Margin % | -48.43 | |||||
ROE % | -15.86 | |||||
ROA % | -9.91 | |||||
ROIC % | -44.13 | |||||
ROC (Joel Greenblatt) % | -76.49 | |||||
ROCE % | -15.79 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 4.79 | |||||
PB Ratio | 2 | |||||
Price-to-Tangible-Book | 2 | |||||
EV-to-EBIT | -5.27 | |||||
EV-to-Forward-EBIT | -3.76 | |||||
EV-to-EBITDA | -5.94 | |||||
EV-to-Forward-EBITDA | -4.21 | |||||
EV-to-Revenue | 2.46 | |||||
EV-to-Forward-Revenue | 37.41 | |||||
EV-to-FCF | -5.49 | |||||
Price-to-Net-Current-Asset-Value | 2.71 | |||||
Price-to-Net-Cash | 2.82 | |||||
Earnings Yield (Greenblatt) % | -18.98 | |||||
FCF Yield % | -9.99 |